Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-105099

Chief Operating Officer gave up 4,472 shares (to pay taxes)

  • Chief Operating Officer acquired 8,789 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BILINSKY IGOR · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-01 Exercise or conversion : show line 1 in the form +8,789 142,709 D
2026-09-01 Shares withheld for taxes : show line 2 in the form −4,472 $8.28 $37,028 138,237 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −8,789 17,580 D
Loading xslF345X06/tm2624648-1_4seq1.xml…